[1]Berry C.W., Brambati B., Eskes T.K. The Euro-Team Early Pregnancy (ETEP) protocol for recurrent miscarriage. Hum Reprod Oxf Engl. 1995;10:1516-1520.
[2]Nybo Andersen A.M., Wohlfahrt J., Christens P., Olsen J., Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708-1712.
[3]Ogasawara M., Aoki K., Okada S., Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73:300-304.
[4]Brigham S.A., Conlon C., Farquharson R.G. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod Oxf Engl. 1999;14:2868-2871.
[5]Toupet A., Théau A., Goffinet F., Tsatsaris V. Recurrent pregnancy losses: Etiological considerations and investigations, the point of view of the obstetrician-gynecologist. Rev Medecine Interne. 2015;36:182-190.
[6]Collège national des gynécologues et obstétriciens français. Recommandations pour la pratique clinique - Les pertes de grossesse (texte court). 2014.
[7]Fryns J.P., Van Buggenhout G. Structural chromosome rearrangements in couples with recurrent fetal wastage. Eur J Obstet Gynecol Reprod Biol. 1998;81:171-176.
[8]Weiss A., Shalev E., Romano S. Hysteroscopy may be justified after two miscarriages. Hum Reprod Oxf Engl. 2005;20:2628-2631.
[9]Lassere M., Empson M. Treatment of antiphospholipid syndrome in pregnancy--a systematic review of randomized therapeutic trials. Thromb Res. 2004;114:419-426.
[10]Empson M., Lassere M., Craig J., Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005CD002859. 2
[11]Arnaud L., Mathian A., Le Thi Huong D., Costedoat-Chalumeau N., Amoura Z. Pregnancy and antiphospholipid syndrome. Rev Médecine Interne. 2011;32:S26-30. Suppl. 1
[12]Nelen W.L., Blom H.J., Steegers E.A., den Heijer M., Eskes T.K. Hyperhomocysteinemia and recurrent early pregnancy loss : a meta-analysis. Fertil Steril. 2000;74:1196-1199.
[13]Gallot V., Nedellec S., Capmas P. Early recurrent miscarriage: Evaluation and management. J Gynecol Obstet Biol Reprod (Paris). 2014;43:812-841.
[14]Makino T. Recurrent reproductive wastage and immunologic factors. Am J Reprod Immunol. 2002;48:266-268.
[15]Twig G., Shina A., Amital H., Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun. 2012;38:J275-281.
[16]Negro R., Schwartz A., Gismondi R., Tinelli A., Mangieri T., Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95:E44-E48.
[17]Hirahara F., Andoh N., Sawai K., Hirabuki T., Uemura T., Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril. 1998;70:246-252.
[18]Levi A.J., Raynault M.F., Bergh P.A., Drews M.R., Miller B.T., Scott R.T. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001;76:666-669.
[20]Cocksedge K.A., Saravelos S.H., Metwally M., Li T.C. How common is polycystic ovary syndrome in recurrent miscarriage? Reprod Biomed Online. 2009;19:572-576.
[21]Temple R., Aldridge V., Greenwood R., Heyburn P., Sampson M., Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ. 2002;325:1275-1276.
[22]Andersen A-MN, Andersen P.K., Olsen J., Grønbæk M., Strandberg-Larsen K. Moderate alcohol intake during pregnancy and risk of fetal death. Int J Epidemiol. 2012;41:405-413.
[23]Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003;189:139-147.
[24]Jauniaux E., Farquharson R.G., Christiansen O.B., Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod Oxf Engl. 2006;21:2216-2222.